Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer
- PMID: 17009625
Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer
Abstract
Purpose: To determine the usefulness of local mitomycin C application in the prophylaxis of vaginal narrowing after irradiation.
Material and methods: 31 patients with advanced cervical cancer qualified for the study. They underwent brachytherapy with iridium-192 isotope and external beam therapy with linear accelerators. In a blind probe method 16 patients were chosen to have an aqueous solution of mitomycin C applied to the vagina.
Results: Radiotherapy caused a shortening of vaginal length in both groups (study and control). In the "mitomycin C group" complete vaginal occlusion was visibly less frequent as were solid fibrotic vault changes.
Conclusions: This mode of morbidity prevention can potentially diminish the occurrence of local vaginal fibrosis and thus may improve patients' quality of life. Further investigations are needed to confirm these results.
Similar articles
-
Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.BMC Cancer. 2021 Jun 10;21(1):682. doi: 10.1186/s12885-021-08274-w. BMC Cancer. 2021. PMID: 34112100 Free PMC article. Clinical Trial.
-
Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.Radiother Oncol. 2016 Sep;120(3):480-485. doi: 10.1016/j.radonc.2016.05.020. Epub 2016 Jun 3. Radiother Oncol. 2016. PMID: 27267048
-
High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.Int J Gynecol Cancer. 2002 Jan-Feb;12(1):27-31. doi: 10.1046/j.1525-1438.2002.01072.x. Int J Gynecol Cancer. 2002. PMID: 11860533
-
Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.Gynecol Oncol. 1996 Jan;60(1):64-71. doi: 10.1006/gyno.1996.0013. Gynecol Oncol. 1996. PMID: 8557230 Review.
-
[Complications of treatments of invasive cancers of the uterine cervix with intact uterus: results and prevention].Cancer Radiother. 2000 Mar-Apr;4(2):147-58. doi: 10.1016/s1278-3218(00)88899-x. Cancer Radiother. 2000. PMID: 10812361 Review. French.
Cited by
-
Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study.BMC Cancer. 2015 Apr 2;15:214. doi: 10.1186/s12885-015-1236-7. BMC Cancer. 2015. PMID: 25884958 Free PMC article.
-
Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).Radiol Med. 2024 Sep;129(9):1329-1351. doi: 10.1007/s11547-024-01844-5. Epub 2024 Aug 28. Radiol Med. 2024. PMID: 39198369 Free PMC article.
-
The impact of vaginal dilator use on vaginal stenosis and sexual quality of life in women treated with adjuvant radiotherapy for endometrial cancer.Strahlenther Onkol. 2019 Oct;195(10):902-912. doi: 10.1007/s00066-019-01466-1. Epub 2019 Apr 17. Strahlenther Onkol. 2019. PMID: 30997541 English.
-
Vaginal dilator therapy for women receiving pelvic radiotherapy.Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007291. doi: 10.1002/14651858.CD007291.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2014 Sep 08;(9):CD007291. doi: 10.1002/14651858.CD007291.pub3. PMID: 20824858 Free PMC article. Updated.
-
Vaginal dilator therapy for women receiving pelvic radiotherapy.Cochrane Database Syst Rev. 2014 Sep 8;2014(9):CD007291. doi: 10.1002/14651858.CD007291.pub3. Cochrane Database Syst Rev. 2014. PMID: 25198150 Free PMC article.